Frontlight ResearchEarly access
Trial site
University of Fukui Hospital
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Childhood cancers2 trials
- Acute lymphoblastic leukaemia1 trial
- Atrial fibrillation1 trial
- Colorectal cancer1 trial
- Prostate cancer1 trial
- Stroke1 trial
- Systemic sclerosis (scleroderma)1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 1/22 trials
- Phase 32 trials
- Phase 11 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Janssen Pharmaceutical K.K.2 trials
- Kyowa Kirin Co., Ltd.1 trial
- Medtronic Cardiac Ablation Solutions1 trial
- National Cancer Center Hospital East1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia2 recruiting
- Stroke1 recruiting
Closed trials
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Completed
A Study of Guselkumab in Participants With Systemic Sclerosis
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026